Kim Dajung

5PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersMolecular targetsNanotoxicology, health and safetyMedical physicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2026
Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.

|Apr 28, 2025
A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI-eIF2α-ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies.

Min-Jung Kim, Jinsook Kwak, Hyung Seok Kim

|Feb 09, 2023
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea.

Jae-Cheol Jo, Youngwoo Jeon, DaJung Kim

|Nov 20, 2022
Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party.

Sung-Hoon Jung, Kihyun Kim, Sang Eun Yoon

|Apr 21, 2020
A Case of Preleukemic Chronic Myeloid Leukemia Following Chemotherapy and Autologous Transplantation for T-lymphoblastic Lymphoma.

Hyunji Choi, Sung Ran Cho, Dahae Yang

Pageof 1

Frequent Collaborators

2 joint publications

Ho Sup Lee

1 joint publications

Hyunji Choi

1 joint publications

Sung Ran Cho

1 joint publications

Dahae Yang